Logout succeed
Logout succeed. See you again!

2015 Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coron PDF
Preview 2015 Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coron
1 Protective efficacy of recombinant Modified Vaccinia virus Ankara (MVA) delivering 1 Middle East Respiratory Syndrome coronavirus spike glycoprotein 2 3 4 Asisa Volz1, Alexandra Kupke2, Fei Song1, Sylvia Jany1, Robert Fux1, Hosam Shams-Eldin2, 5 Jörg Schmidt2, Christin Becker3, Markus Eickmann2, Stephan Becker2, and Gerd Sutter1 # 6 7 1German Centre for Infection Research (DZIF), Institute for Infectious Diseases and 8 Zoonoses, LMU University of Munich, Munich, Veterinaerstrasse 13, D-80539 Munich, 9 Germany; 10 2German Centre for Infection Research (DZIF), Institute of Virology, Philipps University 11 Marburg, Marburg, Germany; 12 3University of Giessen Lung Center, Department of Internal Medicine II, Section of Infectious 13 Diseases, Giessen, Germany; 14 15 Running title: Protective immunization with MVA-MERS-S vaccine 16 17 Abstract: 75 words 18 Text: 1202 words 19 20 #corresponding author: